Development of Next-Generation Vaccines Online Summit 2022 – Free Registration
Online event on 8 – 9 June 2022
Please complete this form to apply for your FREE PASS to view Drug Target Review’s Development of Next-Generation Vaccines Online Summit 2022 on-demand.
With an unprecedented acceleration in vaccine development seen over the past two years, the spotlight is now focused on the next generation of vaccines. Watch our online event which took place on 8 – 9 June 2022 to learn more on vaccine development innovation – from COVID-19 to cancer vaccines to bioinformatics.
We have some absolutely fantastic speakers lined up for you:
– Dr Mark Doherty, Senior Medical Manager at GlaxoSmithKline discusses therapeutics vaccines and immunotherapies to modify existing or new immune responses to prevent the development of disease
– Dr Yingxia Wen, Senior Director, Head of Discovery Research at Seqirus explores innovation in mRNA vaccines
– Dr John Lewis, CEO of Entos Pharmaceuticals details his work into delivering DNA vaccines using a proteolipid platform.
*Free passes are limited to active researchers from pharmaceutical companies, biotech organisations, research centres, academic institutes and CROs and will be allocated on a first-come first-served basis. Registrations will only be accepted with an affiliated organisation/company email address.
A member of the team will be in contact with further details regarding your access to our sessions.
